New stage 4 colorectal cancer treatments offer hope
Lauren Dias, MD, a Mass General Brigham Cancer Institute oncologist, describes how new treatment discoveries continue to improve patient outcomes and survival rates.
We are home to one of the largest hospital system-based research enterprises in the U.S., with an annual research budget of nearly $2 billion. There are over 3,700 ongoing clinical trials to accelerate bringing new treatments and therapies to our patients and the world.